Orthocell Ltd has released a press release.
Ethics Approval for Pivotal Ortho ATI Tendon Study Received
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- United States Tendon Stem Cell and Scaffold Patent Obtained
- Chinese Patent Received Covering Celgro SMART Graft
- Early Positive Results for CelGro in Human Tendon Study
- Orthocell Receives Approval for Human Hip Study Using Celgro
- Cell Factory Concept Further Validated in Leading Journal
Later from Orthocell
- Approval for CelGro Human Nerve Regeneration Study Received
- Orthocell Announces Growth Factor - Cell factory Publication
- Orthocell Announces $4 million Capital Raising
- Orthocell Announces Collaboration with Johnson & Johnson
- Orthocell Cell Factory Patent Granted in Europe
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell